Literature DB >> 9247911

Estrogen receptor status of breast cancer: a marker of different stages of tumor or different entities of the disease?

K Zhu1, L J Bernard, R S Levine, S M Williams.   

Abstract

Breast cancer can be divided into two types according to the estrogen receptor (ER) level of the tumor: ER-positive and ER-negative. Two hypotheses have been raised about the relationship between ER-positive and ER-negative breast tumors. One hypothesis considers ER status as an indicator of a different stage of the disease. The other regards ER-positive and ER-negative tumors as different entities. For both etiological and biological studies of breast cancer it is important to know which hypothesis is correct. In this paper, we review evidence for and against each hypothesis and suggest issues to be addressed in future studies.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9247911     DOI： 10.1016/s0306-9877(97)90255-3

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


  6 in total

1.  Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions.

Authors:  Nancy Krieger; Jarvis T Chen; James H Ware; Afamia Kaddour
Journal:  Cancer Causes Control       Date:  2008-08-14       Impact factor: 2.506

2.  Fruit and vegetable intake and risk of breast cancer by hormone receptor status.

Authors:  Seungyoun Jung; Donna Spiegelman; Laura Baglietto; Leslie Bernstein; Deborah A Boggs; Piet A van den Brandt; Julie E Buring; James R Cerhan; Mia M Gaudet; Graham G Giles; Gary Goodman; Niclas Hakansson; Susan E Hankinson; Kathy Helzlsouer; Pamela L Horn-Ross; Manami Inoue; Vittorio Krogh; Marie Lof; Marjorie L McCullough; Anthony B Miller; Marian L Neuhouser; Julie R Palmer; Yikyung Park; Kim Robien; Thomas E Rohan; Stephanie Scarmo; Catherine Schairer; Leo J Schouten; James M Shikany; Sabina Sieri; Schoichiro Tsugane; Kala Visvanathan; Elisabete Weiderpass; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Shumin M Zhang; Xuehong Zhang; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  J Natl Cancer Inst       Date:  2013-01-24       Impact factor: 13.506

3.  Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study.

Authors:  A P Høyer; T Jørgensen; F Rank; P Grandjean
Journal:  BMC Cancer       Date:  2001-07-30       Impact factor: 4.430

4.  The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983-1999.

Authors:  S O Dalton; M Düring; L Ross; K Carlsen; P B Mortensen; J Lynch; C Johansen
Journal:  Br J Cancer       Date:  2006-08-08       Impact factor: 7.640

5.  Night shift work, chemical coexposures and risk of female breast cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort: a prospectively recruited case-cohort study.

Authors:  Fei Chih Liu; Marit Bragelien Veierød; Kristina Kjærheim; Trude Eid Robsahm; Reza Ghiasvand; H Dean Hosgood; Sven Ove Samuelsen; Magne Bråtveit; Jorunn Kirkeleit; Nathaniel Rothman; Qing Lan; Debra T Silverman; Melissa C Friesen; Ronnie Babigumira; Nita Shala; Tom K Grimsrud; Jo Steinson Stenehjem
Journal:  BMJ Open       Date:  2022-01-24       Impact factor: 2.692

6.  Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study.

Authors:  Tricia M Peters; Arthur Schatzkin; Gretchen L Gierach; Steven C Moore; James V Lacey; Nicholas J Wareham; Ulf Ekelund; Albert R Hollenbeck; Michael F Leitzmann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.